FIELD: medicine.
SUBSTANCE: present invention concerns medicine, namely - to oncology and can be used for treatment of a cancer at a mammal. The way under the invention includes introduction of ditosylate salt N-{3-chloride-4-[(3-fluobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethylene]amino}methyl)-2-furyl]-4-quinazoline amine (chemical combination 1) monohydrate and capecitabine.
EFFECT: depression of risk of advance of disease.
2 tbl, 7 ex
